Adjustable Artificial Sphincter Victo in the Treatment of Male Incontinence Due to Prostate Surgery

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorUniversity Hospital Ostrava

About this trial

The aim of this prospective academic research study is to evaluate the efficacy and safety of the Victo adjustable artificial sphincter in the treatment of male patients with urinary incontinence due to prostate surgery.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

urinary incontinence due to previous prostate surgery

primo-implantation of the artificial urinary sphincter

subject willing and able to give informed consent

Disqualifiers

None

Trial population

Patients with moderate to severe incontinence due to previous prostate surgery, seeking medical help (implantation of the artificial urinary sphincter)

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

  • 24-h pad-weight test

    Other intervention

    The patients will be asked to perform the 24-h pad-weight test

  • Patient Global Impression - Improvement Questionnaire

    Other intervention

    The patient-reported outcome, as measured by PGI-I (Patient Global Impression - Improvement Questionnaire)

Treatment groups

150 Participants
are divided into 1 treatment group
Group A: Urinary incontinence due to prostate surgery2 interventions

Trial outcomes

Primary outcomes

1

Severity of incontinence as measured using 24-hour pad-weight test (24PWT)

The severity of incontinence will be measured using the 24PWT. The patients will be asked to perform the test three times, and the average weight of the three measurements will be recorded. The change in severity of incontinence as measured by 24PWT will be observed from baseline to the end of observation.

Time frame
72 hours

Secondary outcomes

1

Patients-reported outcomes of treatment

The patients-reported outcomes will be measured using the Patient Global Impression of Improvement (PGI-I) index. The Patient Global Impression of Improvement (PGI-I) is a global index that may be used to rate the response of a condition to a therapy. The PGI-I is a transition scale that is a single question asking the patient to rate their urinary tract condition now, as compared with how it was prior to beginning treatment on a scale from 1. (Very much better) to 7. (Very much worse).

Time frame
5 years
2

Treatment safety assessment

The safety of treatment will be measured by evaluation of the reported treatment-related complications using the Clavien-Dindo classification. The Clavien-Dindo system is widely used throughout surgery for grading adverse events (i.e. complications) which occur as a result of surgical procedures.

Time frame
5 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.